Breaking News

Over a week ago
Show Full Stories

X

To view all stories in expanded form, please subscribe.
Send Info
Hot Stocks
ClearPoint Neuro, Philips enter license and research agreement for Maestro » 16:43
02/18/21
02/18
16:43
02/18/21
16:43
CLPT

ClearPoint Neuro

$25.75 /

-1.82 (-6.60%)

, PHG

Philips

$56.81 /

-0.505 (-0.88%)

ClearPoint Neuro (CLPT)…

ClearPoint Neuro (CLPT) announced a worldwide license and research agreement with Philips (PHG), to commercialize the ClearPoint 'Maestro' Brain Model. The company expects the first-generation anatomical segment analysis tool to be launched in 2022.

ShowHide Related Items >><<
PHG Philips
$56.81 /

-0.505 (-0.88%)

CLPT ClearPoint Neuro
$25.75 /

-1.82 (-6.60%)

CLPT ClearPoint Neuro
$25.75 /

-1.82 (-6.60%)

01/22/21 B. Riley Securities
ClearPoint Neuro price target raised to $23 from $18 at B. Riley Securities
01/12/21 B. Riley Securities
ClearPoint Neuro price target raised to $18 from $16 at B. Riley Securities
11/11/20 B. Riley Securities
ClearPoint Neuro price target raised to $10.50 from $8 at B. Riley Securities
09/10/20 B. Riley Securities
ClearPoint Neuro added to top ideas list at B. Riley FBR
PHG Philips
$56.81 /

-0.505 (-0.88%)

01/26/21 Credit Suisse
Philips price target raised to EUR 45 from EUR 41 at Credit Suisse
01/26/21 JPMorgan
Philips price target raised to EUR 44.90 from EUR 44 at JPMorgan
01/26/21 UBS
Philips price target raised to EUR 54 from EUR 51 at UBS
01/25/21 Morgan Stanley
iRhythm price target raised to $288 from $227 at Morgan Stanley
PHG Philips
$56.81 /

-0.505 (-0.88%)

PHG Philips
$56.81 /

-0.505 (-0.88%)

PHG Philips
$56.81 /

-0.505 (-0.88%)

Hot Stocks
Investors Bancorp to replace BioTelemetry in S&P 600 at open on 2/10 » 04:55
02/10/21
02/10
04:55
02/10/21
04:55
ISBC

Investors Bancorp

$12.72 /

+0.36 (+2.91%)

, BEAT

BioTelemetry

$71.96 /

+ (+0.00%)

, PHG

Philips

$57.08 /

+0.71 (+1.26%)

Koninklijke Philips N.V.…

Koninklijke Philips N.V. (PHG) is acquiring Biotelemetry (BEAT) in a deal expected to be completed soon pending final conditions.

ShowHide Related Items >><<
PHG Philips
$57.08 /

+0.71 (+1.26%)

ISBC Investors Bancorp
$12.72 /

+0.36 (+2.91%)

BEAT BioTelemetry
$71.96 /

+ (+0.00%)

ISBC Investors Bancorp
$12.72 /

+0.36 (+2.91%)

04/01/20 Keefe Bruyette
Investors Bancorp upgraded to Outperform from Market Perform at Keefe Bruyette
BEAT BioTelemetry
$71.96 /

+ (+0.00%)

01/25/21 Morgan Stanley
iRhythm price target raised to $288 from $227 at Morgan Stanley
12/29/20 Truist
BioTelemetry downgraded to Hold from Buy at Truist
12/18/20 Sidoti
BioTelemetry downgraded to Neutral from Buy at Sidoti
12/03/20 Benchmark
BioTelemetry price target raised to $64 from $52 at Benchmark
PHG Philips
$57.08 /

+0.71 (+1.26%)

01/26/21 Credit Suisse
Philips price target raised to EUR 45 from EUR 41 at Credit Suisse
01/26/21 JPMorgan
Philips price target raised to EUR 44.90 from EUR 44 at JPMorgan
01/26/21 UBS
Philips price target raised to EUR 54 from EUR 51 at UBS
PHG Philips
$57.08 /

+0.71 (+1.26%)

ISBC Investors Bancorp
$12.72 /

+0.36 (+2.91%)

BEAT BioTelemetry
$71.96 /

+ (+0.00%)

PHG Philips
$57.08 /

+0.71 (+1.26%)

PHG Philips
$57.08 /

+0.71 (+1.26%)

BEAT BioTelemetry
$71.96 /

+ (+0.00%)

Hot Stocks
Garmin wins initial determination in Philips patent dispute » 08:35
02/05/21
02/05
08:35
02/05/21
08:35
GRMN

Garmin

$119.22 /

+0.27 (+0.23%)

, PHG

Philips

$56.76 /

+0.32 (+0.57%)

Garmin International, a…

Garmin International, a unit of Garmin (GRMN), announced victory in a trade lawsuit brought by Philips North America and Koninklijke Philips (PHG) against Garmin. An Administrative Law Judge, or ALJ, at the International Trade Commission, or ITC, issued an initial determination on February 4, finding that Philips' asserted patents were invalid and did not cover Garmin's popular wearable devices. The initial determination is subject to review by the ITC.

ShowHide Related Items >><<
PHG Philips
$56.76 /

+0.32 (+0.57%)

GRMN Garmin
$119.22 /

+0.27 (+0.23%)

GRMN Garmin
$119.22 /

+0.27 (+0.23%)

02/04/21 JPMorgan
Garmin price target raised to $133 from $112 at JPMorgan
12/16/20 Morgan Stanley
Garmin price target raised to $123 from $106 at Morgan Stanley
12/08/20 Deutsche Bank
Garmin initiated with a Hold at Deutsche Bank
11/10/20 Credit Suisse
Garmin price target raised to $107 from $96 at Credit Suisse
PHG Philips
$56.76 /

+0.32 (+0.57%)

01/26/21 Credit Suisse
Philips price target raised to EUR 45 from EUR 41 at Credit Suisse
01/26/21 JPMorgan
Philips price target raised to EUR 44.90 from EUR 44 at JPMorgan
01/26/21 UBS
Philips price target raised to EUR 54 from EUR 51 at UBS
01/25/21 Morgan Stanley
iRhythm price target raised to $288 from $227 at Morgan Stanley
PHG Philips
$56.76 /

+0.32 (+0.57%)

GRMN Garmin
$119.22 /

+0.27 (+0.23%)

PHG Philips
$56.76 /

+0.32 (+0.57%)

PHG Philips
$56.76 /

+0.32 (+0.57%)

Hot Stocks
Philips, Dutch SAZ sign five-year strategic partnership » 05:10
02/04/21
02/04
05:10
02/04/21
05:10
PHG

Philips

$56.44 /

-0.38 (-0.67%)

Philips and the Dutch SAZ…

Philips and the Dutch SAZ group of 28 hospitals have signed a strategic partnership agreement for a minimum of five years in the field of connected care. The partnership will encompass the monitoring, observation and self-management of patients throughout the entire care journey, both inside and outside the hospitals, supported by Philips advanced patient monitoring and population health management solutions. The company said, "During the course of 2021 about ten SAZ hospitals will start the collaboration focused either on hospital care or care in the community. In-hospital applications will include early detection of patient deterioration on nursing wards using Philips' IntelliVue Guardian Solution, which the Bravis hospital in Bergen op Zoom and Roosendaal, the Netherlands, already has experience of using. The Bravis hospital is also already using Philips' wearable biosensor and will use it to make a better connection between patient monitoring in the hospital's ICU and its nursing wards, reducing the length of stay in the ICU and helping to prevent ICU re-admissions. In addition, the solution will help a patient to return to a long term care setting or their own home. By creating an automatic link between the Philips biosensor, the Philips IntelliVue Guardian software and the hospital's EMR system, the organization aims to reduce the time nurses spend on administration. Other hospitals will start projects in the field of home monitoring and self-management for patients, something that IJsselland Hospital in Capelle aan den IJssel, the Netherlands, is already doing with Philips as part of a telemonitoring project for patients with heart failure and COPD. Patients measure their blood pressure and weight at home, and this data is monitored by heart failure nurses in the hospital. Patients also receive additional information and tips on how to manage their condition. The aim is to prevent readmissions and increase patient engagement, something that will be supported by Philips' patient-centric Engage platform, which provides patient and provider access to an overview of the patient's health information. The SAZ has experience with multiparty collaborations to improve healthcare. In 2017 the 28 hospitals started the company BeterDichtbij BV. BeterDichtbij is now used by 35 hospitals in the Netherlands. As part of the strategic collaboration between SAZ a connection will be realized between BeterDichtbij and the Philips Engage platform."

ShowHide Related Items >><<
PHG Philips
$56.44 /

-0.38 (-0.67%)

PHG Philips
$56.44 /

-0.38 (-0.67%)

01/26/21 Credit Suisse
Philips price target raised to EUR 45 from EUR 41 at Credit Suisse
01/26/21 JPMorgan
Philips price target raised to EUR 44.90 from EUR 44 at JPMorgan
01/26/21 UBS
Philips price target raised to EUR 54 from EUR 51 at UBS
01/25/21 Morgan Stanley
iRhythm price target raised to $288 from $227 at Morgan Stanley
PHG Philips
$56.44 /

-0.38 (-0.67%)

PHG Philips
$56.44 /

-0.38 (-0.67%)

PHG Philips
$56.44 /

-0.38 (-0.67%)

Hot Stocks
Investors Bancorp to replace BioTelemetry in S&P 600 at open on 2/10 » 17:18
02/02/21
02/02
17:18
02/02/21
17:18
ISBC

Investors Bancorp

$11.72 /

+0.23 (+2.00%)

, BEAT

BioTelemetry

$71.70 /

-0.045 (-0.06%)

, PHG

Philips

$56.79 /

+0.57 (+1.01%)

Koninklijke Philips N.V.…

Koninklijke Philips N.V. (PHG) is acquiring Biotelemetry (BEAT) in a deal expected to be completed soon pending final conditions.

ShowHide Related Items >><<
PHG Philips
$56.79 /

+0.57 (+1.01%)

ISBC Investors Bancorp
$11.72 /

+0.23 (+2.00%)

BEAT BioTelemetry
$71.70 /

-0.045 (-0.06%)

ISBC Investors Bancorp
$11.72 /

+0.23 (+2.00%)

04/01/20 Keefe Bruyette
Investors Bancorp upgraded to Outperform from Market Perform at Keefe Bruyette
BEAT BioTelemetry
$71.70 /

-0.045 (-0.06%)

01/25/21 Morgan Stanley
iRhythm price target raised to $288 from $227 at Morgan Stanley
12/29/20 Truist
BioTelemetry downgraded to Hold from Buy at Truist
12/18/20 Sidoti
BioTelemetry downgraded to Neutral from Buy at Sidoti
12/03/20 Benchmark
BioTelemetry price target raised to $64 from $52 at Benchmark
PHG Philips
$56.79 /

+0.57 (+1.01%)

01/26/21 Credit Suisse
Philips price target raised to EUR 45 from EUR 41 at Credit Suisse
01/26/21 JPMorgan
Philips price target raised to EUR 44.90 from EUR 44 at JPMorgan
01/26/21 UBS
Philips price target raised to EUR 54 from EUR 51 at UBS
PHG Philips
$56.79 /

+0.57 (+1.01%)

ISBC Investors Bancorp
$11.72 /

+0.23 (+2.00%)

BEAT BioTelemetry
$71.70 /

-0.045 (-0.06%)

PHG Philips
$56.79 /

+0.57 (+1.01%)

PHG Philips
$56.79 /

+0.57 (+1.01%)

BEAT BioTelemetry
$71.70 /

-0.045 (-0.06%)

Hot Stocks
Philips introduces ClarifEye augmented reality surgical navigation solution » 05:23
02/02/21
02/02
05:23
02/02/21
05:23
PHG

Philips

$56.20 /

+1.85 (+3.40%)

Philips introduced…

Philips introduced ClarifEye augmented reality surgical navigation, a solution to advance minimally-invasive spine procedures in the Hybrid Operating Room, such as Philips' Hybrid Suite. By combining 2D and 3D visualizations at low X-ray dose with 3D augmented reality, or AR, the solution provides live intra-operative visual feedback to support accurate placement of pedicle screws during spinal fusion procedures. During such procedures, two or more vertebrae in the spine are permanently connected to help improve stability, correct a deformity, or reduce pain. The solution is fully integrated into the Philips Azurion image-guided therapy platform, supporting workflow with intra-procedural navigation and verification for accurate screw placement and reducing the need for post-operative CT scans.

ShowHide Related Items >><<
PHG Philips
$56.20 /

+1.85 (+3.40%)

PHG Philips
$56.20 /

+1.85 (+3.40%)

01/26/21 Credit Suisse
Philips price target raised to EUR 45 from EUR 41 at Credit Suisse
01/26/21 JPMorgan
Philips price target raised to EUR 44.90 from EUR 44 at JPMorgan
01/26/21 UBS
Philips price target raised to EUR 54 from EUR 51 at UBS
01/25/21 Morgan Stanley
iRhythm price target raised to $288 from $227 at Morgan Stanley
PHG Philips
$56.20 /

+1.85 (+3.40%)

PHG Philips
$56.20 /

+1.85 (+3.40%)

PHG Philips
$56.20 /

+1.85 (+3.40%)

Hot Stocks
Philips launches Medical Tablet remote patient management solution » 09:16
02/01/21
02/01
09:16
02/01/21
09:16
PHG

Philips

$54.35 /

-1.76 (-3.14%)

Royal Philips introduced…

Royal Philips introduced the Philips Medical Tablet, an end-to-end portable monitoring kit designed to help clinicians remotely monitor larger patient populations during emergency situations, like the COVID-19 pandemic. The Medical Tablet integrates with Philips advanced IntelliVue XDS software to enable remote access of patient monitoring information. This solution can therefore be operated through WiFi connection.

ShowHide Related Items >><<
PHG Philips
$54.35 /

-1.76 (-3.14%)

PHG Philips
$54.35 /

-1.76 (-3.14%)

01/26/21 Credit Suisse
Philips price target raised to EUR 45 from EUR 41 at Credit Suisse
01/26/21 JPMorgan
Philips price target raised to EUR 44.90 from EUR 44 at JPMorgan
01/26/21 UBS
Philips price target raised to EUR 54 from EUR 51 at UBS
01/25/21 Morgan Stanley
iRhythm price target raised to $288 from $227 at Morgan Stanley
PHG Philips
$54.35 /

-1.76 (-3.14%)

PHG Philips
$54.35 /

-1.76 (-3.14%)

PHG Philips
$54.35 /

-1.76 (-3.14%)

Over a month ago
Recommendations
Philips price target raised to EUR 45 from EUR 41 at Credit Suisse » 13:28
01/26/21
01/26
13:28
01/26/21
13:28
PHG

Philips

$57.67 /

+0.68 (+1.19%)

Credit Suisse analyst Max…

Credit Suisse analyst Max Yates raised the firm's price target on Philips to EUR 45 from EUR 41 and keeps a Neutral rating on the shares.

ShowHide Related Items >><<
PHG Philips
$57.67 /

+0.68 (+1.19%)

PHG Philips
$57.67 /

+0.68 (+1.19%)

01/26/21 JPMorgan
Philips price target raised to EUR 44.90 from EUR 44 at JPMorgan
01/26/21 UBS
Philips price target raised to EUR 54 from EUR 51 at UBS
01/25/21 Morgan Stanley
iRhythm price target raised to $288 from $227 at Morgan Stanley
01/20/21 Berenberg
Philips price target raised to EUR 50 from EUR 49 at Berenberg
PHG Philips
$57.67 /

+0.68 (+1.19%)

PHG Philips
$57.67 /

+0.68 (+1.19%)

PHG Philips
$57.67 /

+0.68 (+1.19%)

Recommendations
Philips price target raised to EUR 44.90 from EUR 44 at JPMorgan » 13:20
01/26/21
01/26
13:20
01/26/21
13:20
PHG

Philips

$57.60 /

+0.61 (+1.07%)

JPMorgan analyst David…

JPMorgan analyst David Adlington raised the firm's price target on Philips to EUR 44.90 from EUR 44 and keeps a Neutral rating on the shares.

ShowHide Related Items >><<
PHG Philips
$57.60 /

+0.61 (+1.07%)

PHG Philips
$57.60 /

+0.61 (+1.07%)

01/26/21 UBS
Philips price target raised to EUR 54 from EUR 51 at UBS
01/25/21 Morgan Stanley
iRhythm price target raised to $288 from $227 at Morgan Stanley
01/20/21 Berenberg
Philips price target raised to EUR 50 from EUR 49 at Berenberg
01/19/21 JPMorgan
Philips price target raised to EUR 44 from EUR 39.40 at JPMorgan
PHG Philips
$57.60 /

+0.61 (+1.07%)

PHG Philips
$57.60 /

+0.61 (+1.07%)

PHG Philips
$57.60 /

+0.61 (+1.07%)

Recommendations
Philips price target raised to EUR 54 from EUR 51 at UBS » 12:45
01/26/21
01/26
12:45
01/26/21
12:45
PHG

Philips

$57.55 /

+0.56 (+0.98%)

UBS analyst Matthew…

UBS analyst Matthew Taylor raised the firm's price target on Philips to EUR 54 from EUR 51 and keeps a Buy rating on the shares.

ShowHide Related Items >><<
PHG Philips
$57.55 /

+0.56 (+0.98%)

PHG Philips
$57.55 /

+0.56 (+0.98%)

01/25/21 Morgan Stanley
iRhythm price target raised to $288 from $227 at Morgan Stanley
01/20/21 Berenberg
Philips price target raised to EUR 50 from EUR 49 at Berenberg
01/19/21 JPMorgan
Philips price target raised to EUR 44 from EUR 39.40 at JPMorgan
11/12/20 Berenberg
Philips price target raised to EUR 49 from EUR 46 at Berenberg
PHG Philips
$57.55 /

+0.56 (+0.98%)

PHG Philips
$57.55 /

+0.56 (+0.98%)

PHG Philips
$57.55 /

+0.56 (+0.98%)

Get Full Fly Access

Breaking market intelligence sent straight to you
Our team of experts analyze every news story and filter out the noise to deliver real-time market moving news.
Up-to-date information on important industry events
Get real-time updates on events that are moving the market—from conferences and calls to syndicate announcements.
News focused on the companies in your portfolio
Create up to 12 portfolios with 150 stocks each, and see how active they are in market news.